|
Mechanismthrombin inhibitors |
Active Org.- |
|
Active Indication- |
|
Drug Highest PhaseDiscontinued |
First Approval Ctry. / Loc.- |
First Approval Date- |
|
MechanismH1 receptor antagonists [+1] |
Active Org.- |
|
Active Indication- |
|
Drug Highest PhaseDiscontinued |
First Approval Ctry. / Loc.- |
First Approval Date- |
|
|
Active Org.- |
|
Active Indication- |
|
Drug Highest PhaseDiscontinued |
First Approval Ctry. / Loc.- |
First Approval Date- |
A PATIENT PREFERENCE STUDY OF FROVATRIPTAN VERSUS ZOLMITRIPTAN FOR THE ACUTE TREATMENT OF MIGRAINE - ND
ASSESSMENT OF EFFECTS OF A 12-MONTH TREATMENT WITH METFORMIN ON INSULIN ACTION AND SECRETION IN WOMEN WITH PRIOR GESTATIONAL DIABETES MELLITUS (GDM)
EFFICACY AND SAFETY OF OLMESARTAN IN ELDERLY PATIENTS WITH MILD TO MODERATE HYPERTENSION
100 Clinical Results associated with Guidotti SRL
0 Patents (Medical) associated with Guidotti SRL
100 Deals associated with Guidotti SRL
100 Translational Medicine associated with Guidotti SRL